Omeros Corporation (OMER)
USD 7.25
(-1.49%)
USD 7.25
(-1.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 403.25 Million USD | -20.19% |
| 2022 | 505.28 Million USD | 27.76% |
| 2021 | 395.48 Million USD | 31.05% |
| 2020 | 301.79 Million USD | 22.69% |
| 2019 | 245.99 Million USD | 5929.15% |
| 2018 | -4.22 Million USD | -103.54% |
| 2017 | 119.14 Million USD | 13.77% |
| 2016 | 104.72 Million USD | 39.21% |
| 2015 | 75.22 Million USD | 39.98% |
| 2014 | 53.74 Million USD | 53.91% |
| 2013 | 34.91 Million USD | -85.52% |
| 2012 | 241.15 Million USD | 641.19% |
| 2011 | 32.53 Million USD | 28.94% |
| 2010 | 25.23 Million USD | 33.39% |
| 2009 | 18.91 Million USD | -83.24% |
| 2008 | 112.84 Million USD | 16.21% |
| 2007 | 97.1 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 508.82 Million USD | 26.18% |
| 2024 Q2 | 480.91 Million USD | -5.48% |
| 2023 Q3 | 507.02 Million USD | 0.02% |
| 2023 Q4 | 403.25 Million USD | -20.47% |
| 2023 Q1 | 505.19 Million USD | -0.02% |
| 2023 FY | 403.25 Million USD | -20.19% |
| 2023 Q2 | 506.91 Million USD | 0.34% |
| 2022 Q2 | 378.34 Million USD | 1.11% |
| 2022 Q3 | 503.86 Million USD | 33.18% |
| 2022 Q4 | 505.28 Million USD | 0.28% |
| 2022 FY | 505.28 Million USD | 27.76% |
| 2022 Q1 | 374.18 Million USD | -5.39% |
| 2021 Q2 | 391.68 Million USD | 2.16% |
| 2021 FY | 395.48 Million USD | 31.05% |
| 2021 Q4 | 395.48 Million USD | 2.42% |
| 2021 Q3 | 386.12 Million USD | -1.42% |
| 2021 Q1 | 383.39 Million USD | 27.04% |
| 2020 Q2 | 231.95 Million USD | -7.25% |
| 2020 Q3 | 314.4 Million USD | 35.54% |
| 2020 FY | 301.79 Million USD | 22.69% |
| 2020 Q4 | 301.79 Million USD | -4.01% |
| 2020 Q1 | 250.07 Million USD | 1.66% |
| 2019 Q1 | 222.26 Million USD | 5366.94% |
| 2019 FY | 245.99 Million USD | 5929.15% |
| 2019 Q4 | 245.99 Million USD | 6.41% |
| 2019 Q3 | 231.17 Million USD | 5.06% |
| 2019 Q2 | 220.03 Million USD | -1.0% |
| 2018 Q2 | 162.64 Million USD | 37.54% |
| 2018 Q1 | 118.25 Million USD | -0.75% |
| 2018 FY | -4.22 Million USD | -103.54% |
| 2018 Q4 | -4.22 Million USD | -102.56% |
| 2018 Q3 | 164.6 Million USD | 1.21% |
| 2017 Q3 | 116.3 Million USD | 0.96% |
| 2017 Q2 | 115.2 Million USD | 8.16% |
| 2017 Q1 | 106.51 Million USD | 1.71% |
| 2017 FY | 119.14 Million USD | 13.77% |
| 2017 Q4 | 119.14 Million USD | 2.44% |
| 2016 Q3 | 95.53 Million USD | 0.45% |
| 2016 Q1 | 76.71 Million USD | 1.97% |
| 2016 FY | 104.72 Million USD | 39.21% |
| 2016 Q4 | 104.72 Million USD | 9.62% |
| 2016 Q2 | 95.1 Million USD | 23.97% |
| 2015 Q1 | 53.06 Million USD | -1.26% |
| 2015 FY | 75.22 Million USD | 39.98% |
| 2015 Q4 | 75.22 Million USD | 49.2% |
| 2015 Q3 | 50.42 Million USD | -0.56% |
| 2015 Q2 | 50.7 Million USD | -4.45% |
| 2014 FY | 53.74 Million USD | 53.91% |
| 2014 Q4 | 53.74 Million USD | 3.59% |
| 2014 Q3 | 51.88 Million USD | 0.54% |
| 2014 Q2 | 51.6 Million USD | 1.47% |
| 2014 Q1 | 50.85 Million USD | 45.64% |
| 2013 FY | 34.91 Million USD | -85.52% |
| 2013 Q4 | 34.91 Million USD | -2.75% |
| 2013 Q2 | 35.31 Million USD | 5.24% |
| 2013 Q1 | 33.55 Million USD | -86.08% |
| 2013 Q3 | 35.9 Million USD | 1.68% |
| 2012 Q3 | 33.58 Million USD | 9.73% |
| 2012 FY | 241.15 Million USD | 641.19% |
| 2012 Q2 | 30.6 Million USD | -9.38% |
| 2012 Q4 | 241.15 Million USD | 618.12% |
| 2012 Q1 | 33.77 Million USD | 3.8% |
| 2011 Q4 | 32.53 Million USD | 5.27% |
| 2011 FY | 32.53 Million USD | 28.94% |
| 2011 Q3 | 30.9 Million USD | -0.08% |
| 2011 Q2 | 30.93 Million USD | -6.49% |
| 2011 Q1 | 33.08 Million USD | 31.1% |
| 2010 Q4 | 25.23 Million USD | 77.78% |
| 2010 Q2 | 14.98 Million USD | -9.15% |
| 2010 FY | 25.23 Million USD | 33.39% |
| 2010 Q1 | 16.49 Million USD | -12.79% |
| 2010 Q3 | 14.19 Million USD | -5.3% |
| 2009 FY | 18.91 Million USD | -83.24% |
| 2009 Q4 | 18.91 Million USD | -83.14% |
| 2009 Q3 | 112.2 Million USD | -1.86% |
| 2009 Q2 | 114.33 Million USD | 0.0% |
| 2008 Q4 | 112.84 Million USD | 0.0% |
| 2008 FY | 112.84 Million USD | 16.21% |
| 2007 FY | 97.1 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AbCellera Biologics Inc. | 335.77 Million USD | -20.096% |
| Alkermes plc | 933.53 Million USD | 56.804% |
| Agenus Inc. | 462.29 Million USD | 12.772% |
| Alnylam Pharmaceuticals, Inc. | 4.05 Billion USD | 90.044% |
| Aptorum Group Limited | 5.25 Million USD | -7571.145% |
| Ardelyx, Inc. | 130.76 Million USD | -208.384% |
| Arrowhead Pharmaceuticals, Inc. | 478.39 Million USD | 15.706% |
| Bicycle Therapeutics plc | 224.41 Million USD | -79.693% |
| BioXcel Therapeutics, Inc. | 130.21 Million USD | -209.694% |
| ChromaDex Corporation | 26.5 Million USD | -1421.246% |
| Chimerix, Inc. | 19.74 Million USD | -1942.299% |
| Corbus Pharmaceuticals Holdings, Inc. | 35.17 Million USD | -1046.348% |
| Caribou Biosciences, Inc. | 72.56 Million USD | -455.696% |
| CRISPR Therapeutics AG | 346.76 Million USD | -16.289% |
| Precision BioSciences, Inc. | 140.92 Million USD | -186.157% |
| Dyadic International, Inc. | 2.34 Million USD | -17128.198% |
| Eton Pharmaceuticals, Inc. | 16.26 Million USD | -2379.567% |
| Fortress Biotech, Inc. | 165.93 Million USD | -143.012% |
| Lantern Pharma Inc. | 2.73 Million USD | -14618.935% |
| HOOKIPA Pharma Inc. | 71.48 Million USD | -464.147% |
| Inhibikase Therapeutics, Inc. | 3.52 Million USD | -11327.697% |
| Incyte Corporation | 1.59 Billion USD | 74.674% |
| IO Biotech, Inc. | 17.55 Million USD | -2196.947% |
| Jaguar Health, Inc. | 45.86 Million USD | -779.196% |
| Novavax, Inc. | 2.57 Billion USD | 84.323% |
| Janux Therapeutics, Inc. | 36.05 Million USD | -1018.343% |
| Opthea Limited | 264.6 Million USD | -52.4% |
| Ligand Pharmaceuticals Incorporated | 130.7 Million USD | -208.516% |
| ContextLogic Inc. | 206 Million USD | -95.753% |
| MiMedx Group, Inc. | 96.33 Million USD | -318.615% |
| Pyxis Oncology, Inc. | 48.02 Million USD | -739.723% |
| TransCode Therapeutics, Inc. | 3.52 Million USD | -11327.172% |
| NextCure, Inc. | 14.99 Million USD | -2588.884% |
| Ocuphire Pharma, Inc. | 4.04 Million USD | -9876.546% |
| Oncternal Therapeutics, Inc. | 6.67 Million USD | -5939.419% |
| Outlook Therapeutics, Inc. | 46.73 Million USD | -762.774% |
| Vaxcyte, Inc. | 167.44 Million USD | -140.821% |
| PDS Biotechnology Corporation | 33.25 Million USD | -1112.455% |
| Madrigal Pharmaceuticals, Inc. | 235.21 Million USD | -71.44% |
| Pharming Group N.V. | 244.07 Million USD | -65.218% |
| Pieris Pharmaceuticals, Inc. | 11.92 Million USD | -3282.419% |
| Avidity Biosciences, Inc. | 127.79 Million USD | -215.556% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -6003.148% |
| Reviva Pharmaceuticals Holdings, Inc. | 6.6 Million USD | -6003.148% |
| Sangamo Therapeutics, Inc. | 82.43 Million USD | -389.188% |
| Sol-Gel Technologies Ltd. | 6.64 Million USD | -5970.33% |
| Acelyrin, Inc. | 86.35 Million USD | -366.981% |
| Salarius Pharmaceuticals, Inc. | 1.29 Million USD | -30937.506% |
| SELLAS Life Sciences Group, Inc. | 14.37 Million USD | -2704.451% |
| Summit Therapeutics Inc. | 125.25 Million USD | -221.94% |
| Sensei Biotherapeutics, Inc. | 9.47 Million USD | -4154.162% |
| Senti Biosciences, Inc. | 52.57 Million USD | -667.062% |
| Stoke Therapeutics, Inc. | 68.77 Million USD | -486.318% |
| Syros Pharmaceuticals, Inc. | 151.51 Million USD | -166.152% |
| Alaunos Therapeutics, Inc. | 1.95 Million USD | -20516.155% |
| Telomir Pharmaceuticals, Inc. Common Stock | 1.33 Million USD | -30093.386% |
| Entrada Therapeutics, Inc. | 226.83 Million USD | -77.776% |
| VistaGen Therapeutics, Inc. | 9.36 Million USD | -4205.028% |
| Wave Life Sciences Ltd. | 227.44 Million USD | -77.296% |
| Sorrento Therapeutics, Inc. | 494.5 Million USD | 18.454% |
| TRACON Pharmaceuticals, Inc. | 10.91 Million USD | -3594.814% |
| Barinthus Biotherapeutics plc | 27.51 Million USD | -1365.785% |
| Psyence Biomedical Ltd. | 12.1 Million USD | -3231.367% |
| Phathom Pharmaceuticals, Inc. | 486.6 Million USD | 17.129% |
| Immix Biopharma, Inc. | 3.72 Million USD | -10734.914% |
| Keros Therapeutics, Inc. | 37.81 Million USD | -966.466% |
| MEI Pharma, Inc. | 8.35 Million USD | -4726.475% |
| Windtree Therapeutics, Inc. | 29.01 Million USD | -1289.805% |
| Xeris Biopharma Holdings, Inc. | 347.58 Million USD | -16.017% |
| Rigel Pharmaceuticals, Inc. | 145.86 Million USD | -176.448% |
| Fortress Biotech, Inc. | 165.93 Million USD | -143.012% |
| Precigen, Inc. | 41.64 Million USD | -868.332% |
| Clearside Biomedical, Inc. | 49.93 Million USD | -707.635% |
| AlloVir, Inc. | 45.01 Million USD | -795.817% |
| C4 Therapeutics, Inc. | 130.33 Million USD | -209.392% |
| Fate Therapeutics, Inc. | 137.8 Million USD | -192.636% |
| ImmuCell Corporation | 18.81 Million USD | -2043.245% |
| IDEAYA Biosciences, Inc. | 28.22 Million USD | -1328.654% |
| Onconetix, Inc. | 23.18 Million USD | -1639.588% |
| PureTech Health plc | 125.58 Million USD | -221.104% |
| VYNE Therapeutics Inc. | 8.95 Million USD | -4405.609% |
| Elevation Oncology, Inc. | 34.28 Million USD | -1076.279% |
| Kintara Therapeutics, Inc. | 2.44 Million USD | -16392.924% |
| Seer, Inc. | 39.36 Million USD | -924.392% |
| Verrica Pharmaceuticals Inc. | 61.83 Million USD | -552.153% |
| Innoviva, Inc. | 568.55 Million USD | 29.074% |
| Aadi Bioscience, Inc. | 27.22 Million USD | -1381.02% |
| ESSA Pharma Inc. | 3.49 Million USD | -11437.734% |
| GlycoMimetics, Inc. | 6.9 Million USD | -5742.476% |
| GT Biopharma, Inc. | 6.63 Million USD | -5979.481% |
| Inhibrx Biosciences, Inc. | 264.39 Million USD | -52.522% |
| Akebia Therapeutics, Inc. | 272.28 Million USD | -48.098% |
| Catalyst Pharmaceuticals, Inc. | 84.02 Million USD | -379.913% |
| Longboard Pharmaceuticals, Inc. | 9.77 Million USD | -4025.762% |
| Orchestra BioMed Holdings, Inc. | 27.16 Million USD | -1384.236% |
| Alzamend Neuro, Inc. | 3.22 Million USD | -12400.942% |
| Rocket Pharmaceuticals, Inc. | 73.76 Million USD | -446.656% |
| Aptose Biosciences Inc. | 15.8 Million USD | -2450.823% |
| ZyVersa Therapeutics, Inc. | 11.03 Million USD | -3552.749% |
| Soligenix, Inc. | 7.27 Million USD | -5443.056% |
| Century Therapeutics, Inc. | 175.94 Million USD | -129.197% |
| Kura Oncology, Inc. | 51.66 Million USD | -680.558% |
| TScan Therapeutics, Inc. | 121.28 Million USD | -232.491% |
| Intensity Therapeutics, Inc. | 4.13 Million USD | -9656.884% |
| Ocean Biomedical, Inc. | 6.61 Million USD | -5997.08% |
| CytomX Therapeutics, Inc. | 252.59 Million USD | -59.642% |
| Autolus Therapeutics plc | 263.9 Million USD | -52.801% |
| Mineralys Therapeutics, Inc. | 10.48 Million USD | -3747.09% |
| EyePoint Pharmaceuticals, Inc. | 88.86 Million USD | -353.801% |
| Eterna Therapeutics Inc. | 46.89 Million USD | -759.831% |
| Adaptive Biotechnologies Corporation | 352.85 Million USD | -14.282% |
| GRI Bio, Inc. | 2.69 Million USD | -14851.872% |
| Xenetic Biosciences, Inc. | 809.58 Thousand USD | -49709.717% |
| Tenaya Therapeutics, Inc. | 31.09 Million USD | -1197.006% |
| IGM Biosciences, Inc. | 220.17 Million USD | -83.149% |
| INmune Bio, Inc. | 18.86 Million USD | -2037.907% |
| Heron Therapeutics, Inc. | 256.47 Million USD | -57.226% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1413.606% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -14734.134% |
| Entero Therapeutics, Inc. | 3.28 Million USD | -12193.271% |
| Milestone Pharmaceuticals Inc. | 58.45 Million USD | -589.85% |
| X4 Pharmaceuticals, Inc. | 96.15 Million USD | -319.36% |
| Atara Biotherapeutics, Inc. | 264.73 Million USD | -52.323% |
| Coherus BioSciences, Inc. | 823.02 Million USD | 51.004% |
| Verastem, Inc. | 71.18 Million USD | -466.485% |
| Abeona Therapeutics Inc. | 49.17 Million USD | -720.018% |
| Pliant Therapeutics, Inc. | 38.57 Million USD | -945.29% |
| Tonix Pharmaceuticals Holding Corp. | 48.93 Million USD | -724.107% |
| Histogen Inc. | 5.69 Million USD | -6978.322% |
| Aprea Therapeutics, Inc. | 4.38 Million USD | -9094.9% |
| Surrozen, Inc. | 8.14 Million USD | -4850.915% |
| Organovo Holdings, Inc. | 2.74 Million USD | -14574.381% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -128382.307% |
| Ovid Therapeutics Inc. | 56.22 Million USD | -617.149% |
| Panbela Therapeutics, Inc. | 16.51 Million USD | -2342.175% |
| CASI Pharmaceuticals, Inc. | 51.1 Million USD | -689.097% |
| Cadrenal Therapeutics, Inc. Common Stock | 826.87 Thousand USD | -48668.193% |
| Centessa Pharmaceuticals plc | 126.72 Million USD | -218.21% |
| Hepion Pharmaceuticals, Inc. | 10.81 Million USD | -3629.122% |
| Arcturus Therapeutics Holdings Inc. | 150.88 Million USD | -167.251% |
| BioRestorative Therapies, Inc. | 2.6 Million USD | -15366.001% |
| Apollomics, Inc. | 14.15 Million USD | -2749.233% |
| Amarin Corporation plc | 279.58 Million USD | -44.231% |
| Mesoblast Limited | 188.79 Million USD | -113.589% |
| Turnstone Biologics Corp. | 14.14 Million USD | -2750.24% |
| Kymera Therapeutics, Inc. | 180.78 Million USD | -123.052% |
| Synaptogenix, Inc. | 5.52 Million USD | -7192.78% |
| Tiziana Life Sciences Ltd | 6.64 Million USD | -5965.764% |
| Aurinia Pharmaceuticals Inc. | 170.1 Million USD | -137.056% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -4612.433% |
| Monopar Therapeutics Inc. | 1.75 Million USD | -22846.034% |
| Exelixis, Inc. | 678.44 Million USD | 40.562% |
| Better Therapeutics, Inc. | 23.84 Million USD | -1591.351% |
| Nurix Therapeutics, Inc. | 164.04 Million USD | -145.816% |
| Apellis Pharmaceuticals, Inc. | 594.2 Million USD | 32.136% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3675.696% |
| Dermata Therapeutics, Inc. | 1.62 Million USD | -24736.661% |
| Aridis Pharmaceuticals, Inc. | 38.92 Million USD | -935.919% |
| Gritstone bio, Inc. | 125.91 Million USD | -220.247% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2647.697% |
| TNF Pharmaceuticals, Inc. | 5.08 Million USD | -7824.574% |
| Avid Bioservices, Inc. | 275.66 Million USD | -46.282% |
| Insmed Incorporated | 1.66 Billion USD | 75.733% |
| Virpax Pharmaceuticals, Inc. | 7.69 Million USD | -5141.107% |
| MediWound Ltd. | 27.18 Million USD | -1383.253% |
| OmniAb, Inc. | 87.4 Million USD | -361.387% |
| Alector, Inc. | 487.66 Million USD | 17.31% |
| Seres Therapeutics, Inc. | 403.45 Million USD | 0.051% |
| Checkpoint Therapeutics, Inc. | 18.42 Million USD | -2088.613% |
| Viracta Therapeutics, Inc. | 38.37 Million USD | -950.874% |
| Zai Lab Limited | 240.17 Million USD | -67.898% |
| Revance Therapeutics, Inc. | 630.05 Million USD | 35.998% |
| Aura Biosciences, Inc. | 29.22 Million USD | -1279.724% |
| Lyell Immunopharma, Inc. | 95.07 Million USD | -324.132% |
| Immunic, Inc. | 25.36 Million USD | -1489.609% |
| Tarsus Pharmaceuticals, Inc. | 69.23 Million USD | -482.431% |
| Veracyte, Inc. | 93.71 Million USD | -330.278% |
| InMed Pharmaceuticals Inc. | 2.61 Million USD | -15310.867% |
| FibroGen, Inc. | 585.72 Million USD | 31.154% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2219.807% |
| Adial Pharmaceuticals, Inc. | 653.07 Thousand USD | -61646.565% |
| Sonnet BioTherapeutics Holdings, Inc. | 5.65 Million USD | -7030.316% |
| Jazz Pharmaceuticals plc | 7.65 Billion USD | 94.733% |
| Cyclacel Pharmaceuticals, Inc. | 8.19 Million USD | -4818.907% |
| Amylyx Pharmaceuticals, Inc. | 84.02 Million USD | -379.936% |
| TG Therapeutics, Inc. | 169.08 Million USD | -138.491% |
| Galecto, Inc. | 5.89 Million USD | -6739.417% |
| Calithera Biosciences, Inc. | 8.28 Million USD | -4767.842% |
| Fortrea Holdings Inc. | 2.61 Billion USD | 84.599% |
| KalVista Pharmaceuticals, Inc. | 28.82 Million USD | -1299.112% |
| Aptevo Therapeutics Inc. | 12.62 Million USD | -3095.088% |
| XBiotech Inc. | 8.39 Million USD | -4702.334% |
| Jasper Therapeutics, Inc. | 14.67 Million USD | -2647.697% |
| Lyra Therapeutics, Inc. | 53.18 Million USD | -658.278% |
| Foghorn Therapeutics Inc. | 363.1 Million USD | -11.056% |
| Y-mAbs Therapeutics, Inc. | 26.88 Million USD | -1399.97% |
| Theravance Biopharma, Inc. | 169 Million USD | -138.605% |
| Ultragenyx Pharmaceutical Inc. | 1.21 Billion USD | 66.827% |
| Metagenomi, Inc. Common Stock | 500.42 Million USD | 19.418% |
| Vaxxinity, Inc. | 30.94 Million USD | -1203.167% |
| BioCryst Pharmaceuticals, Inc. | 972.48 Million USD | 58.534% |
| Gain Therapeutics, Inc. | 6.03 Million USD | -6586.202% |
| Cartesian Therapeutics, Inc. | 745.23 Million USD | 45.889% |
| NexImmune, Inc. | 5.08 Million USD | -7831.424% |
| Creative Medical Technology Holdings, Inc. | 371.39 Thousand USD | -108477.952% |
| Marker Therapeutics, Inc. | 3.07 Million USD | -13014.534% |
| Regeneron Pharmaceuticals, Inc. | 7.1 Billion USD | 94.326% |
| Chemomab Therapeutics Ltd. | 5.15 Million USD | -7724.013% |
| Scopus BioPharma Inc. | 7.45 Million USD | -5309.559% |
| RAPT Therapeutics, Inc. | 26.29 Million USD | -1433.627% |
| Ainos, Inc. | 7.39 Million USD | -5353.609% |
| Pluri Inc. | 34.11 Million USD | -1082.141% |
| Prothena Corporation plc | 135.01 Million USD | -198.668% |
| Adaptimmune Therapeutics plc | 243.1 Million USD | -65.877% |
| Celularity Inc. | 102.92 Million USD | -291.777% |
| Rallybio Corporation | 9.43 Million USD | -4173.548% |
| Cue Biopharma, Inc. | 24.44 Million USD | -1549.63% |
| MeiraGTx Holdings plc | 319.99 Million USD | -26.02% |
| Humacyte, Inc. | 114.67 Million USD | -251.642% |
| Immunocore Holdings plc | 228.15 Million USD | -76.742% |
| Cocrystal Pharma, Inc. | 4.87 Million USD | -8171.836% |
| Cidara Therapeutics, Inc. | 76.74 Million USD | -425.478% |
| Blueprint Medicines Corporation | 918.64 Million USD | 56.103% |
| CalciMedica, Inc. | 4.02 Million USD | -9911.221% |
| Cabaletta Bio, Inc. | 17.45 Million USD | -2210.635% |
| Marinus Pharmaceuticals, Inc. | 154.14 Million USD | -161.609% |
| Scholar Rock Holding Corporation | 85.81 Million USD | -369.898% |
| Sana Biotechnology, Inc. | 277.79 Million USD | -45.163% |
| Pulmatrix, Inc. | 15.96 Million USD | -2426.167% |
| Elicio Therapeutics, Inc. | 15.77 Million USD | -2456.597% |
| Vigil Neuroscience, Inc. | 24.6 Million USD | -1538.836% |
| Intellia Therapeutics, Inc. | 250.8 Million USD | -60.781% |
| Adlai Nortye Ltd. American Depositary Shares | 50.78 Million USD | -694.022% |
| Cytokinetics, Incorporated | 1.21 Billion USD | 66.691% |
| Eloxx Pharmaceuticals, Inc. | 31.78 Million USD | -1168.766% |
| Nutriband Inc. | 1.07 Million USD | -37275.558% |
| Protara Therapeutics, Inc. | 10.63 Million USD | -3692.457% |
| Vor Biopharma Inc. | 59.1 Million USD | -582.275% |
| Roivant Sciences Ltd. | 773.95 Million USD | 47.897% |
| Evogene Ltd. | 17.99 Million USD | -2141.534% |
| ProKidney Corp. | 29.21 Million USD | -1280.244% |
| Applied Therapeutics, Inc. | 71.97 Million USD | -460.236% |
| Hoth Therapeutics, Inc. | 704.98 Thousand USD | -57100.245% |
| BridgeBio Pharma, Inc. | 1.88 Billion USD | 78.652% |
| CorMedix Inc. | 11.91 Million USD | -3283.688% |
| BioLineRx Ltd. | 50.7 Million USD | -695.337% |
| Tango Therapeutics, Inc. | 149.45 Million USD | -169.808% |
| Galectin Therapeutics Inc. | 88.44 Million USD | -355.956% |
| Atai Life Sciences N.V. | 49.16 Million USD | -720.251% |
| Renovaro Biosciences Inc. | 31.15 Million USD | -1194.453% |
| Aerovate Therapeutics, Inc. | 17.96 Million USD | -2145.028% |
| Zentalis Pharmaceuticals, Inc. | 124.63 Million USD | -223.544% |
| Sagimet Biosciences Inc. | 5.65 Million USD | -7032.154% |
| MediciNova, Inc. | 3.89 Million USD | -10262.238% |
| Praxis Precision Medicines, Inc. | 18.27 Million USD | -2106.094% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -26707.672% |
| GeoVax Labs, Inc. | 3.51 Million USD | -11356.41% |
| Axsome Therapeutics, Inc. | 397.25 Million USD | -1.509% |
| Biomea Fusion, Inc. | 30.69 Million USD | -1213.952% |
| PTC Therapeutics, Inc. | 2.72 Billion USD | 85.184% |
| Mereo BioPharma Group plc | 15.96 Million USD | -2426.325% |
| Cullinan Oncology, Inc. | 31.2 Million USD | -1192.433% |
| Syndax Pharmaceuticals, Inc. | 58.68 Million USD | -587.158% |
| Absci Corporation | 58.3 Million USD | -591.637% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2017.031% |
| 4D Molecular Therapeutics, Inc. | 32.06 Million USD | -1157.726% |
| Dyne Therapeutics, Inc. | 73.79 Million USD | -446.486% |
| Kiniksa Pharmaceuticals, Ltd. | 87.48 Million USD | -360.949% |
| Ventyx Biosciences, Inc. | 33.77 Million USD | -1094.113% |
| Allakos Inc. | 74.79 Million USD | -439.157% |
| Imunon, Inc. | 8.53 Million USD | -4627.219% |
| Fulcrum Therapeutics, Inc. | 22.5 Million USD | -1692.151% |
| Corcept Therapeutics Incorporated | 114.81 Million USD | -251.228% |
| BioAtla, Inc. | 48.98 Million USD | -723.198% |
| NLS Pharmaceutics AG | 10.68 Million USD | -3675.696% |
| Bio-Path Holdings, Inc. | 2.77 Million USD | -14410.687% |
| Allogene Therapeutics, Inc. | 130.6 Million USD | -208.759% |
| Larimar Therapeutics, Inc. | 14.21 Million USD | -2736.806% |
| XOMA Corporation | 145.58 Million USD | -176.997% |
| Kezar Life Sciences, Inc. | 33.66 Million USD | -1097.838% |
| Cara Therapeutics, Inc. | 68.75 Million USD | -486.472% |
| aTyr Pharma, Inc. | 31.59 Million USD | -1176.235% |
| Aligos Therapeutics, Inc. | 61.82 Million USD | -552.269% |
| Akero Therapeutics, Inc. | 44.96 Million USD | -796.813% |
| Viridian Therapeutics, Inc. | 48.4 Million USD | -733.131% |
| Eliem Therapeutics, Inc. | 2.87 Million USD | -13950.592% |
| EyeGate Pharmaceuticals, Inc. | 8.15 Million USD | -4843.014% |
| Akari Therapeutics, Plc | 4.58 Million USD | -8696.946% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2174.004% |
| Halozyme Therapeutics, Inc. | 1.64 Billion USD | 75.553% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -99737.587% |
| UroGen Pharma Ltd. | 243.52 Million USD | -65.591% |
| Sutro Biopharma, Inc. | 321.08 Million USD | -25.59% |
| ZIVO Bioscience, Inc. | 2.76 Million USD | -14502.337% |
| Orgenesis Inc. | 35.53 Million USD | -1034.802% |
| Entera Bio Ltd. | 1.37 Million USD | -29142.35% |
| GH Research PLC | 6.7 Million USD | -5917.788% |
| Lisata Therapeutics, Inc. | 6.8 Million USD | -5830.176% |
| Reneo Pharmaceuticals, Inc. | 18.82 Million USD | -2041.995% |
| Xencor, Inc. | 283.55 Million USD | -42.211% |
| 60 Degrees Pharmaceuticals, Inc. | 2.98 Million USD | -13406.226% |
| Replimune Group, Inc. | 113.21 Million USD | -256.186% |
| Coeptis Therapeutics Holdings, Inc. | 3.75 Million USD | -10632.994% |
| Vanda Pharmaceuticals Inc. | 103.53 Million USD | -289.503% |
| Lexaria Bioscience Corp. | 403.9 Thousand USD | -99737.587% |
| Portage Biotech Inc. | 4.45 Million USD | -8961.843% |
| Cardio Diagnostics Holdings, Inc. | 1.5 Million USD | -26707.672% |
| Olema Pharmaceuticals, Inc. | 23.05 Million USD | -1649.466% |
| OncoCyte Corporation | 49.29 Million USD | -717.989% |
| Qualigen Therapeutics, Inc. | 4.13 Million USD | -9647.909% |
| Processa Pharmaceuticals, Inc. | 797.48 Thousand USD | -50465.529% |
| Purple Biotech Ltd. | 10 Million USD | -3930.505% |
| CollPlant Biotechnologies Ltd. | 5.78 Million USD | -6869.443% |
| scPharmaceuticals Inc. | 57.26 Million USD | -604.235% |
| ProMIS Neurosciences, Inc. | 12.38 Million USD | -3155.177% |
| HilleVax, Inc. | 78.9 Million USD | -411.034% |
| NeuroSense Therapeutics Ltd. | 5.05 Million USD | -7885.188% |
| Tharimmune, Inc. | 1.81 Million USD | -22117.178% |
| Genprex, Inc. | 3.25 Million USD | -12291.709% |
| Neumora Therapeutics, Inc. Common Stock | 27.11 Million USD | -1386.972% |
| Atossa Therapeutics, Inc. | 5.23 Million USD | -7601.528% |
| XTL Biopharmaceuticals Ltd. | 206 Thousand USD | -195653.398% |
| Virios Therapeutics, Inc. | 358.54 Thousand USD | -112368.066% |
| OKYO Pharma Limited | 7.42 Million USD | -5334.044% |
| Savara Inc. | 37.19 Million USD | -984.244% |
| Curis, Inc. | 57.61 Million USD | -599.944% |
| Daré Bioscience, Inc. | 26.32 Million USD | -1431.539% |
| Carmell Therapeutics Corporation | 39.19 Million USD | -928.71% |
| Titan Pharmaceuticals, Inc. | 1.44 Million USD | -27826.039% |
| Achieve Life Sciences, Inc. | 20.81 Million USD | -1836.942% |
| BeiGene, Ltd. | 2.23 Billion USD | 81.947% |
| Kiromic BioPharma, Inc. | 21.28 Million USD | -1794.109% |
| Revolution Medicines, Inc. Warrant | 262.39 Million USD | -53.68% |
| Protagonist Therapeutics, Inc. | 21.27 Million USD | -1795.516% |
| Erasca, Inc. | 78.61 Million USD | -412.971% |
| bluebird bio, Inc. | 424.62 Million USD | 5.033% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -61441.514% |
| BioMarin Pharmaceutical Inc. | 1.89 Billion USD | 78.665% |
| DBV Technologies S.A. | 42.8 Million USD | -842.178% |
| Protagenic Therapeutics, Inc. | 655.25 Thousand USD | -61441.514% |
| Moderna, Inc. | 4.57 Billion USD | 91.18% |
| Vincerx Pharma, Inc. | 6.99 Million USD | -5664.861% |
| Fresh Tracks Therapeutics, Inc. | 1.65 Million USD | -24250.966% |
| Molecular Templates, Inc. | 31.17 Million USD | -1193.677% |
| Acrivon Therapeutics, Inc. Common Stock | 17.07 Million USD | -2262.343% |
| Travere Therapeutics, Inc. | 588.1 Million USD | 31.432% |
| Monte Rosa Therapeutics, Inc. | 124.5 Million USD | -223.884% |
| Spruce Biosciences, Inc. | 27.43 Million USD | -1369.738% |
| Celldex Therapeutics, Inc. | 36.45 Million USD | -1006.133% |
| Cogent Biosciences, Inc. | 55.63 Million USD | -624.817% |
| MacroGenics, Inc. | 154.2 Million USD | -161.5% |
| RenovoRx, Inc. | 4.46 Million USD | -8929.378% |
| Adicet Bio, Inc. | 37.12 Million USD | -986.347% |
| Prime Medicine, Inc. | 60.78 Million USD | -563.462% |
| Aditxt, Inc. | 28.53 Million USD | -1313.354% |
| Adagene Inc. | 45.16 Million USD | -792.756% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -223059.805% |
| Quantum-Si incorporated | 26.63 Million USD | -1414.22% |
| Maravai LifeSciences Holdings, Inc. | 697.56 Million USD | 42.192% |
| Acurx Pharmaceuticals, Inc. | 3.04 Million USD | -13154.239% |
| Voyager Therapeutics, Inc. | 114.96 Million USD | -250.773% |
| SciSparc Ltd. | 1.59 Million USD | -25182.257% |
| Vericel Corporation | 127.7 Million USD | -215.768% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -7146.355% |
| Minerva Neurosciences, Inc. | 85.35 Million USD | -372.424% |
| Generation Bio Co. | 171.63 Million USD | -134.954% |
| Astria Therapeutics, Inc. | 11.55 Million USD | -3391.359% |
| Black Diamond Therapeutics, Inc. | 41.83 Million USD | -864.003% |
| Arcutis Biotherapeutics, Inc. | 252.69 Million USD | -59.579% |
| Invivyd, Inc. | 51.71 Million USD | -679.788% |
| Relay Therapeutics, Inc. | 91.97 Million USD | -338.427% |
| Quoin Pharmaceuticals, Ltd. | 6.5 Million USD | -6098.869% |
| Spero Therapeutics, Inc. | 75.49 Million USD | -434.137% |
| Artelo Biosciences, Inc. | 1.02 Million USD | -39395.788% |
| 2seventy bio, Inc. | 310.12 Million USD | -30.028% |
| ADMA Biologics, Inc. | 193.97 Million USD | -107.888% |
| Clene Inc. | 38.95 Million USD | -935.28% |
| Capricor Therapeutics, Inc. | 36.13 Million USD | -1016.026% |
| Boundless Bio, Inc. Common Stock | 256.97 Million USD | -56.922% |
| GeoVax Labs, Inc. | 3.51 Million USD | -11356.41% |
| Recursion Pharmaceuticals, Inc. | 190.26 Million USD | -111.945% |
| Citius Pharmaceuticals, Inc. | 12.17 Million USD | -3210.864% |
| Contineum Therapeutics, Inc. Class A Common Stock | 198.32 Million USD | -103.332% |
| Relmada Therapeutics, Inc. | 12.19 Million USD | -3206.754% |
| Finch Therapeutics Group, Inc. | 48.11 Million USD | -738.17% |
| ALX Oncology Holdings Inc. | 52.84 Million USD | -663.142% |
| Vir Biotechnology, Inc. | 369.85 Million USD | -9.03% |
| Evaxion Biotech A/S | 17.61 Million USD | -2188.931% |
| Ocular Therapeutix, Inc. | 160.92 Million USD | -150.578% |
| Verve Therapeutics, Inc. | 153.18 Million USD | -163.243% |
| Trevena, Inc. | 48.26 Million USD | -735.548% |
| Surrozen, Inc. | 8.14 Million USD | -4850.915% |
| Tyra Biosciences, Inc. | 21.59 Million USD | -1767.34% |
| Cingulate Inc. | 10.36 Million USD | -3792.069% |
| Galmed Pharmaceuticals Ltd. | 2.75 Million USD | -14563.709% |
| Unity Biotechnology, Inc. | 37.29 Million USD | -981.336% |
| Tenax Therapeutics, Inc. | 3.58 Million USD | -11143.545% |
| Terns Pharmaceuticals, Inc. | 13.15 Million USD | -2966.555% |
| ACADIA Pharmaceuticals Inc. | 317.2 Million USD | -27.128% |
| Connect Biopharma Holdings Limited | 24.84 Million USD | -1522.81% |
| Clearmind Medicine Inc. | 3.61 Million USD | -11070.391% |
| Kronos Bio, Inc. | 54.2 Million USD | -643.994% |
| Bolt Biotherapeutics, Inc. | 47.04 Million USD | -757.199% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1671.778% |
| Viking Therapeutics, Inc. | 20.07 Million USD | -1909.128% |
| Statera Biopharma, Inc. | 22.67 Million USD | -1678.285% |
| ImmunityBio, Inc. | 1.09 Billion USD | 63.018% |
| Korro Bio, Inc. | 51.75 Million USD | -679.201% |
| Kineta, Inc. | 7.22 Million USD | -5483.661% |
| BioVie Inc. | 9.7 Million USD | -4056.324% |
| Codexis, Inc. | 49.94 Million USD | -707.376% |
| Celularity Inc. | 102.92 Million USD | -291.777% |
| Crinetics Pharmaceuticals, Inc. | 96.24 Million USD | -318.976% |
| Celcuity Inc. | 51.45 Million USD | -683.773% |
| Virax Biolabs Group Limited | 345.19 Thousand USD | -116718.948% |
| Cibus, Inc. | 206.11 Million USD | -95.642% |
| Eledon Pharmaceuticals, Inc. | 42.47 Million USD | -849.387% |
| eFFECTOR Therapeutics, Inc. | 26.33 Million USD | -1431.007% |
| IN8bio, Inc. | 8.77 Million USD | -4497.036% |
| Kodiak Sciences Inc. | 213.59 Million USD | -88.796% |
| Annexon, Inc. | 47.11 Million USD | -755.834% |
| Adverum Biotechnologies, Inc. | 89.54 Million USD | -350.355% |
| Assembly Biosciences, Inc. | 96.37 Million USD | -318.433% |
| Avalo Therapeutics, Inc. | 13.68 Million USD | -2845.811% |
| Ionis Pharmaceuticals, Inc. | 2.6 Billion USD | 84.51% |
| Eyenovia, Inc. | 19.78 Million USD | -1938.657% |
| Puma Biotechnology, Inc. | 177.08 Million USD | -127.715% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -5149.993% |
| Xilio Therapeutics, Inc. | 24.09 Million USD | -1573.314% |
| Arcellx, Inc. | 339.75 Million USD | -18.69% |
| Cardiff Oncology, Inc. | 11.89 Million USD | -3289.242% |
| Enanta Pharmaceuticals, Inc. | 245.54 Million USD | -64.231% |
| Regulus Therapeutics Inc. | 9.56 Million USD | -4116.794% |
| Moolec Science SA | 13.94 Million USD | -2791.658% |
| Acumen Pharmaceuticals, Inc. | 43.15 Million USD | -834.492% |
| Geron Corporation | 146.12 Million USD | -175.96% |
| LAVA Therapeutics N.V. | 50.53 Million USD | -698.013% |
| Royalty Pharma plc | 6.29 Billion USD | 93.597% |
| Atea Pharmaceuticals, Inc. | 39.77 Million USD | -913.807% |
| Greenwich LifeSciences, Inc. | 294.4 Thousand USD | -136871.393% |
| TFF Pharmaceuticals, Inc. | 2.46 Million USD | -16290.479% |
| Mersana Therapeutics, Inc. | 189.15 Million USD | -113.185% |
| Humacyte, Inc. | 114.67 Million USD | -251.642% |
| Structure Therapeutics Inc. | 29.05 Million USD | -1288.083% |
| 89bio, Inc. | 59.96 Million USD | -572.501% |
| PMV Pharmaceuticals, Inc. | 26.46 Million USD | -1423.833% |
| Avenue Therapeutics, Inc. | 1.19 Million USD | -33616.722% |
| Genelux Corporation | 8.42 Million USD | -4689.216% |
| Trevi Therapeutics, Inc. | 6.85 Million USD | -5781.739% |
| Lexicon Pharmaceuticals, Inc. | 136.31 Million USD | -195.815% |
| Notable Labs, Ltd. | 4.42 Million USD | -9008.923% |
| Liquidia Corporation | 73.13 Million USD | -451.358% |
| Mustang Bio, Inc. | 17.61 Million USD | -2188.734% |
| Immunovant, Inc. | 48.95 Million USD | -723.72% |
| Quantum-Si incorporated | 26.63 Million USD | -1414.22% |
| Arbutus Biopharma Corporation | 38.38 Million USD | -950.601% |
| DiaMedica Therapeutics Inc. | 3.1 Million USD | -12895.553% |
| Vera Therapeutics, Inc. | 73.86 Million USD | -445.961% |
| Acasti Pharma Inc. | 11.55 Million USD | -3389.245% |
| MiNK Therapeutics, Inc. | 22.6 Million USD | -1683.691% |
| Pasithea Therapeutics Corp. | 2.71 Million USD | -14734.134% |
| Xenon Pharmaceuticals Inc. | 36.87 Million USD | -993.505% |
| Elevai Labs, Inc. Common Stock | 1.36 Million USD | -29489.05% |
| NeuroBo Pharmaceuticals, Inc. | 6.09 Million USD | -6515.026% |
| Tempest Therapeutics, Inc. | 24.83 Million USD | -1523.725% |
| Soleno Therapeutics, Inc. | 23.18 Million USD | -1639.355% |
| PepGen Inc. | 34.63 Million USD | -1064.425% |
| Moleculin Biotech, Inc. | 12.14 Million USD | -3220.586% |
| United Therapeutics Corporation | 1.18 Billion USD | 65.89% |
| Nuvectis Pharma, Inc. | 6.98 Million USD | -5673.94% |
| Solid Biosciences Inc. | 38.45 Million USD | -948.552% |
| BriaCell Therapeutics Corp. | 8.55 Million USD | -4612.433% |
| Immuneering Corporation | 12 Million USD | -3258.095% |
| Lixte Biotechnology Holdings, Inc. | 313.85 Thousand USD | -128382.307% |
| Silo Pharma, Inc. | 1.56 Million USD | -25596.789% |
| Belite Bio, Inc | 4.21 Million USD | -9476.158% |
| XOMA Corporation | 145.58 Million USD | -176.997% |
| ARS Pharmaceuticals, Inc. | 2.42 Million USD | -16508.402% |
| Bionomics Limited | 10.15 Million USD | -3869.515% |
| Apogee Therapeutics, Inc. | 21.49 Million USD | -1776.376% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1659.927% |
| uniQure N.V. | 624.01 Million USD | 35.378% |
| Cassava Sciences, Inc. | 14.19 Million USD | -2740.803% |
| Estrella Immunopharma, Inc. | 180.7 Thousand USD | -223059.805% |
| Poseida Therapeutics, Inc. | 170.18 Million USD | -136.951% |
| Forte Biosciences, Inc. | 3.66 Million USD | -10899.782% |
| Anebulo Pharmaceuticals, Inc. | 260.58 Thousand USD | -154649.926% |
| Enlivex Therapeutics Ltd. | 6.74 Million USD | -5876.76% |
| Conduit Pharmaceuticals Inc. | 7.68 Million USD | -5149.993% |
| SeaStar Medical Holding Corporation | 17.38 Million USD | -2219.807% |
| FibroBiologics, Inc. Common Stock | 10.56 Million USD | -3715.783% |
| Altimmune, Inc. | 16.54 Million USD | -2337.894% |
| Amicus Therapeutics, Inc. | 617.7 Million USD | 34.718% |
| Alpha Tau Medical Ltd. | 22.91 Million USD | -1659.927% |
| Compugen Ltd. | 55.77 Million USD | -622.998% |
| Peak Bio, Inc. | 20.75 Million USD | -1843.068% |
| Zevra Therapeutics, Inc. | 110.46 Million USD | -265.056% |
| Benitec Biopharma Inc. | 4.96 Million USD | -8026.804% |
| Spyre Therapeutics, Inc. | 157.84 Million USD | -155.477% |
| NKGen Biotech, Inc. Common Stock | 75.17 Million USD | -436.425% |
| Zura Bio Limited | 21.29 Million USD | -1793.913% |
| PolyPid Ltd. | 17.46 Million USD | -2208.518% |
| Aileron Therapeutics, Inc. | 112.39 Million USD | -258.768% |
| NKGen Biotech, Inc. Warrants | 75.17 Million USD | -436.425% |
| Instil Bio, Inc. | 99.8 Million USD | -304.056% |
| argenx SE | 444.95 Million USD | 9.372% |
| Immunome, Inc. | 28.65 Million USD | -1307.118% |
| Compass Therapeutics, Inc. | 8.33 Million USD | -4736.896% |
| Verona Pharma plc | 58.84 Million USD | -585.325% |
| enGene Holdings Inc. Warrants | 14.47 Million USD | -2686.236% |
| Shattuck Labs, Inc. | 14.85 Million USD | -2613.857% |
| CervoMed Inc. | 2.59 Million USD | -15435.104% |
| LENZ Therapeutics, Inc. | 4.87 Million USD | -8173.533% |
| Plus Therapeutics, Inc. | 12.73 Million USD | -3066.237% |
| Dianthus Therapeutics, Inc. | 10.53 Million USD | -3727.736% |
| Moolec Science SA | 13.94 Million USD | -2791.658% |
| Enveric Biosciences, Inc. | 2.34 Million USD | -17107.225% |
| Inovio Pharmaceuticals, Inc. | 55.59 Million USD | -625.335% |
| AnaptysBio, Inc. | 364.28 Million USD | -10.697% |
| Design Therapeutics, Inc. | 11.95 Million USD | -3272.8% |
| Leap Therapeutics, Inc. | 12.68 Million USD | -3079.218% |
| NeurAxis, Inc. | 1.91 Million USD | -20982.437% |
| Seelos Therapeutics, Inc. | 38.92 Million USD | -935.892% |
| Lumos Pharma, Inc. | 13.33 Million USD | -2924.466% |
| Achilles Therapeutics plc | 19.08 Million USD | -2012.705% |
| enGene Holdings Inc. Common Stock | 14.47 Million USD | -2686.236% |
| 180 Life Sciences Corp. | 5.38 Million USD | -7385.36% |
| Opiant Pharmaceuticals, Inc. | 23.58 Million USD | -1609.565% |
| CERo Therapeutics Holdings, Inc. | 22.75 Million USD | -1671.778% |
| Nutriband Inc. | 1.07 Million USD | -37275.558% |
| ORIC Pharmaceuticals, Inc. | 30.59 Million USD | -1217.903% |
| CG Oncology, Inc. Common stock | 14.51 Million USD | -2678.94% |
| Fractyl Health, Inc. Common Stock | 401.27 Million USD | -0.493% |
| Rani Therapeutics Holdings, Inc. | 32.47 Million USD | -1141.807% |
| MoonLake Immunotherapeutics | 13.04 Million USD | -2990.268% |
| Palisade Bio, Inc. | 2.73 Million USD | -14622.599% |
| Tourmaline Bio, Inc. | 5.25 Million USD | -7576.604% |
| Beam Therapeutics Inc. | 478.38 Million USD | 15.706% |
| Neurogene Inc. | 36.54 Million USD | -1003.319% |
| Mirum Pharmaceuticals, Inc. | 397.95 Million USD | -1.332% |
| AEON Biopharma, Inc. | 159.88 Million USD | -152.207% |
| CARGO Therapeutics, Inc. Common Stock | 47.65 Million USD | -746.279% |
| Sesen Bio, Inc. | 30.98 Million USD | -1201.485% |
| Enliven Therapeutics, Inc. | 25.96 Million USD | -1453.299% |
| Kiora Pharmaceuticals, Inc. | 7.6 Million USD | -5204.401% |
| Iovance Biotherapeutics, Inc. | 195.73 Million USD | -106.016% |
| Taysha Gene Therapies, Inc. | 192.05 Million USD | -109.965% |
| Athira Pharma, Inc. | 30.05 Million USD | -1241.624% |
| Vaccinex, Inc. | 5.94 Million USD | -6686.469% |
| HCW Biologics Inc. | 15.05 Million USD | -2579.069% |
| XOMA Corporation | 145.58 Million USD | -176.997% |
| Nektar Therapeutics | 267.04 Million USD | -51.005% |
| Arvinas, Inc. | 644.6 Million USD | 37.442% |
| Tevogen Bio Holdings Inc. | 17.73 Million USD | -2174.004% |
| Merus N.V. | 102.15 Million USD | -294.761% |
| Omega Therapeutics, Inc. | 146.35 Million USD | -175.539% |
| Quince Therapeutics, Inc. | 95.12 Million USD | -323.94% |
| Rezolute, Inc. | 11.73 Million USD | -3336.612% |
| Clene Inc. | 38.95 Million USD | -935.28% |
| Indaptus Therapeutics, Inc. | 2.84 Million USD | -14062.212% |
| BeyondSpring Inc. | 48.26 Million USD | -735.426% |
| Synlogic, Inc. | 32.89 Million USD | -1125.876% |
| Allarity Therapeutics, Inc. | 14.61 Million USD | -2659.543% |
| Phio Pharmaceuticals Corp. | 1.63 Million USD | -24578.825% |
| Peak Bio, Inc. | 20.75 Million USD | -1843.068% |
| Werewolf Therapeutics, Inc. | 63.45 Million USD | -535.453% |
| Krystal Biotech, Inc. | 39.71 Million USD | -915.39% |
| Karyopharm Therapeutics Inc. | 376.64 Million USD | -7.064% |
| SpringWorks Therapeutics, Inc. | 99.56 Million USD | -304.998% |
| Lipella Pharmaceuticals Inc. | 432.72 Thousand USD | -93088.761% |
| MannKind Corporation | 721.36 Million USD | 44.099% |
| Ikena Oncology, Inc. | 22.33 Million USD | -1705.471% |
| Cyclerion Therapeutics, Inc. | 2.08 Million USD | -19231.352% |
| Gyre Therapeutics, Inc. | 102.59 Million USD | -293.071% |
| Gossamer Bio, Inc. | 249.14 Million USD | -61.853% |
| CohBar, Inc. | 1.03 Million USD | -38912.885% |
| Cognition Therapeutics, Inc. | 10.68 Million USD | -3672.589% |
| NRx Pharmaceuticals, Inc. | 19.04 Million USD | -2017.031% |
| Legend Biotech Corporation | 589.93 Million USD | 31.644% |
| Mural Oncology plc | 37.92 Million USD | -963.204% |
| Biora Therapeutics, Inc. | 132.63 Million USD | -204.029% |
| PaxMedica, Inc. Common Stock | 2.29 Million USD | -17468.352% |
| Disc Medicine, Inc. | 22.87 Million USD | -1662.85% |
| Champions Oncology, Inc. | 28.03 Million USD | -1338.388% |
| REGENXBIO Inc. | 262.22 Million USD | -53.779% |
| Ensysce Biosciences, Inc. | 3.35 Million USD | -11903.863% |
| Anavex Life Sciences Corp. | 12.53 Million USD | -3117.265% |
| Cellectar Biosciences, Inc. | 13.43 Million USD | -2902.257% |
| Edgewise Therapeutics, Inc. | 21.2 Million USD | -1801.684% |
| Vaxart, Inc. | 34.02 Million USD | -1085.164% |
| PharmaCyte Biotech, Inc. | 20.38 Million USD | -1877.766% |
| Aldeyra Therapeutics, Inc. | 28.53 Million USD | -1313.338% |
| Cellectis S.A. | 249.57 Million USD | -61.575% |
| Longeveron Inc. | 5.33 Million USD | -7455.78% |
| Repare Therapeutics Inc. | 41.81 Million USD | -864.279% |
| Sarepta Therapeutics, Inc. | 2.4 Billion USD | 83.234% |
| Inozyme Pharma, Inc. | 60.36 Million USD | -567.99% |
| Revolution Medicines, Inc. | 262.39 Million USD | -53.68% |
| Nymox Pharmaceutical Corporation | 2.1 Million USD | -19038.681% |
| Third Harmonic Bio, Inc. | 8.62 Million USD | -4574.843% |
| ArriVent BioPharma, Inc. Common Stock | 11.8 Million USD | -3317.1% |
| AN2 Therapeutics, Inc. | 14.04 Million USD | -2771.552% |
| Anixa Biosciences, Inc. | 2.15 Million USD | -18647.187% |
| Vertex Pharmaceuticals Incorporated | 5.14 Billion USD | 92.17% |
| Denali Therapeutics Inc. | 122.96 Million USD | -227.946% |
| Revelation Biosciences, Inc. | 5.56 Million USD | -7146.355% |
| Veru Inc. | 32.81 Million USD | -1128.951% |
| Corvus Pharmaceuticals, Inc. | 6.86 Million USD | -5770.607% |
| Cingulate Inc. | 10.36 Million USD | -3792.069% |
| Passage Bio, Inc. | 39.26 Million USD | -927.08% |
| Context Therapeutics Inc. | 4.19 Million USD | -9520.215% |
| Exicure, Inc. | 8.54 Million USD | -4616.949% |
| Day One Biopharmaceuticals, Inc. | 29.5 Million USD | -1266.585% |
| Oramed Pharmaceuticals Inc. | 10.48 Million USD | -3745.623% |
| Scinai Immunotherapeutics Ltd. | 22.04 Million USD | -1729.554% |
| Rhythm Pharmaceuticals, Inc. | 162.98 Million USD | -147.415% |
| Nuvalent, Inc. | 31.82 Million USD | -1167.172% |
| ABVC BioPharma, Inc. | 6.36 Million USD | -6238.819% |
| Carisma Therapeutics, Inc. | 63.02 Million USD | -539.859% |
| Unicycive Therapeutics, Inc. | 18 Million USD | -2140.289% |
| OmniAb, Inc. | 87.4 Million USD | -361.387% |
| Anew Medical, Inc. | 8.24 Million USD | -4792.767% |
| Fennec Pharmaceuticals Inc. | 38.28 Million USD | -953.177% |
| Lipocine Inc. | 2.63 Million USD | -15223.285% |
| Lexeo Therapeutics, Inc. Common Stock | 26.27 Million USD | -1434.912% |
| Nautilus Biotechnology, Inc. | 40.21 Million USD | -902.815% |
| SAB Biotherapeutics, Inc. | 26.64 Million USD | -1413.606% |
| G1 Therapeutics, Inc. | 86.15 Million USD | -368.06% |
| Bellerophon Therapeutics, Inc. | 5.4 Million USD | -7366.247% |
| Sage Therapeutics, Inc. | 82.74 Million USD | -387.331% |
| Ocugen, Inc. | 23.98 Million USD | -1581.408% |
| Mind Medicine (MindMed) Inc. | 46.4 Million USD | -768.946% |
| Q32 Bio Inc. | 233.12 Million USD | -72.975% |
| Brainstorm Cell Therapeutics Inc. | 9.06 Million USD | -4347.959% |
| Alumis Inc. Common Stock | 53.5 Million USD | -653.714% |
| Equillium, Inc. | 27.95 Million USD | -1342.401% |
| Kyverna Therapeutics, Inc. | 206.59 Million USD | -95.192% |
| Coya Therapeutics, Inc. | 5.62 Million USD | -7066.803% |
| CNS Pharmaceuticals, Inc. | 6.13 Million USD | -6475.153% |
| Galera Therapeutics, Inc. | 157.32 Million USD | -156.316% |
| Evelo Biosciences, Inc. | 69.43 Million USD | -480.779% |
| Comera Life Sciences Holdings, Inc. | 9.97 Million USD | -3942.95% |
| Dominari Holdings Inc. | 4.63 Million USD | -8600.151% |
| Edesa Biotech, Inc. | 1.84 Million USD | -21796.389% |
| vTv Therapeutics Inc. | 29.56 Million USD | -1263.858% |
| Bio-Techne Corporation | 744.34 Million USD | 45.824% |
| Agios Pharmaceuticals, Inc. | 126.09 Million USD | -219.79% |
| Harmony Biosciences Holdings, Inc. | 344.45 Million USD | -17.069% |
| Prelude Therapeutics Incorporated | 40.57 Million USD | -893.843% |
| Candel Therapeutics, Inc. | 28.95 Million USD | -1292.589% |
| iTeos Therapeutics, Inc. | 92.36 Million USD | -336.609% |
| Nkarta, Inc. | 105.6 Million USD | -281.867% |
| BioCardia, Inc. | 4.59 Million USD | -8685.447% |
| Iterum Therapeutics plc | 32.66 Million USD | -1134.621% |